Thuerigen Olaf

520 total citations
4 papers, 395 citations indexed

About

Thuerigen Olaf is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Thuerigen Olaf has authored 4 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Cancer Research. Recurrent topics in Thuerigen Olaf's work include Gene expression and cancer classification (2 papers), Breast Cancer Treatment Studies (2 papers) and HER2/EGFR in Cancer Research (1 paper). Thuerigen Olaf is often cited by papers focused on Gene expression and cancer classification (2 papers), Breast Cancer Treatment Studies (2 papers) and HER2/EGFR in Cancer Research (1 paper). Thuerigen Olaf collaborates with scholars based in Germany, Austria and Switzerland. Thuerigen Olaf's co-authors include Peter Koelblinger, Reinhard Dummer, Hans‐Peter Sinn, Peter Lichter, Carina Ittrich, Beate K. Straub, Stephen Rea, Frank Mendrzyk, Stefan M. Pfister and Mikko Taipale and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and Current Opinion in Oncology.

In The Last Decade

Thuerigen Olaf

3 papers receiving 386 citations

Peers

Thuerigen Olaf
Hélène Malka-Mahieu France
Annette S. Little United Kingdom
Andrew Hudson United Kingdom
Anuj Manandhar United States
Aida Shahrabi Netherlands
Bina Julian United States
Candice L. Horn United States
Sebastian Halbach Germany
Mona Malz Germany
Martine B.W. Prinsen Netherlands
Hélène Malka-Mahieu France
Thuerigen Olaf
Citations per year, relative to Thuerigen Olaf Thuerigen Olaf (= 1×) peers Hélène Malka-Mahieu

Countries citing papers authored by Thuerigen Olaf

Since Specialization
Citations

This map shows the geographic impact of Thuerigen Olaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thuerigen Olaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thuerigen Olaf more than expected).

Fields of papers citing papers by Thuerigen Olaf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thuerigen Olaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thuerigen Olaf. The network helps show where Thuerigen Olaf may publish in the future.

Co-authorship network of co-authors of Thuerigen Olaf

This figure shows the co-authorship network connecting the top 25 collaborators of Thuerigen Olaf. A scholar is included among the top collaborators of Thuerigen Olaf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thuerigen Olaf. Thuerigen Olaf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Koelblinger, Peter, Thuerigen Olaf, & Reinhard Dummer. (2017). Development of encorafenib for BRAF-mutated advanced melanoma. Current Opinion in Oncology. 30(2). 125–133. 125 indexed citations
2.
Pfister, Stefan M., Stephen Rea, Mikko Taipale, et al.. (2007). The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma. International Journal of Cancer. 122(6). 1207–1213. 126 indexed citations
3.
Olaf, Thuerigen, Andreas Schneeweiß, Grischa Toedt, et al.. (2006). Gene Expression Signature Predicting Pathologic Complete Response With Gemcitabine, Epirubicin, and Docetaxel in Primary Breast Cancer. Journal of Clinical Oncology. 24(12). 1839–1845. 144 indexed citations
4.
Schneeweiß, Andreas, Thuerigen Olaf, Grischa Toedt, et al.. (2005). Gene expression profiles predict pathologic complete response to preoperative chemotherapy with gemcitabine, epirubicin and docetaxel in primary breast cancer. Journal of Clinical Oncology. 23(16_suppl). 2001–2001.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hélène Malka-Mahieu Breakdown of academic impact, for papers by Annette S. Little Breakdown of academic impact, for papers by Andrew Hudson Breakdown of academic impact, for papers by Anuj Manandhar Breakdown of academic impact, for papers by Aida Shahrabi Breakdown of academic impact, for papers by Bina Julian Breakdown of academic impact, for papers by Candice L. Horn Breakdown of academic impact, for papers by Sebastian Halbach Breakdown of academic impact, for papers by Mona Malz Breakdown of academic impact, for papers by Martine B.W. Prinsen
Rankless by CCL
2026